As of 2026-05-26, the EV/EBITDA ratio of Anuh Pharma Ltd (506260.BO) is 9.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 506260.BO's latest enterprise value is 7,592.80 mil INR. 506260.BO's TTM EBITDA according to its financial statements is 842.62 mil INR. Dividing these 2 quantities gives us the above 506260.BO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.1x - 11.3x | 10.9x |
| Forward P/E multiples | 8.8x - 10.3x | 9.1x |
| Fair Price | 72.32 - 95.56 | 83.35 |
| Upside | -5.2% - 25.2% | 9.2% |
| Date | EV/EBITDA |
| 2026-05-22 | 8.98 |
| 2026-05-21 | 9.06 |
| 2026-05-20 | 9.42 |
| 2026-05-19 | 9.54 |
| 2026-05-18 | 9.20 |
| 2026-05-15 | 9.27 |
| 2026-05-14 | 9.21 |
| 2026-05-13 | 9.50 |
| 2026-05-12 | 9.51 |
| 2026-05-11 | 9.76 |
| 2026-05-08 | 9.91 |
| 2026-05-07 | 9.79 |
| 2026-05-06 | 9.75 |
| 2026-05-05 | 10.06 |
| 2026-05-04 | 9.40 |
| 2026-04-30 | 9.68 |
| 2026-04-29 | 9.69 |
| 2026-04-28 | 9.79 |
| 2026-04-27 | 9.72 |
| 2026-04-24 | 9.55 |
| 2026-04-23 | 9.64 |
| 2026-04-22 | 9.59 |
| 2026-04-21 | 9.56 |
| 2026-04-20 | 9.57 |
| 2026-04-17 | 9.79 |
| 2026-04-16 | 9.76 |
| 2026-04-15 | 9.53 |
| 2026-04-13 | 9.23 |
| 2026-04-10 | 9.43 |
| 2026-04-09 | 9.24 |
| 2026-04-08 | 8.94 |
| 2026-04-07 | 8.72 |
| 2026-04-06 | 8.64 |
| 2026-04-02 | 8.73 |
| 2026-04-01 | 8.77 |
| 2026-03-30 | 7.97 |
| 2026-03-27 | 8.28 |
| 2026-03-25 | 8.38 |
| 2026-03-24 | 8.40 |
| 2026-03-23 | 8.35 |
| 2026-03-20 | 8.75 |
| 2026-03-19 | 8.76 |
| 2026-03-18 | 9.08 |
| 2026-03-17 | 8.94 |
| 2026-03-16 | 8.92 |
| 2026-03-13 | 9.06 |
| 2026-03-12 | 9.27 |
| 2026-03-11 | 9.33 |
| 2026-03-10 | 9.07 |
| 2026-03-09 | 9.20 |